The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Large And Small-Scale Bioprocessing Market Grow Between 2026 And 2030?
The market size for large and small-scale bioprocessing has experienced swift expansion recently. It is forecast to rise from $67.66 billion in 2025 to $76.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.4%. This historical growth can be attributed to the expansion of biopharmaceutical manufacturing, increased investment in biotechnology R&D, the broader use of fermentation-based production, the rising application of cell culture technologies, and the creation of large-scale stainless steel bioreactors.
The large and small-scale bioprocessing market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $119.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. This expansion over the forecast period is driven by several factors, including the escalating need for biologics and biosimilars, the increasing implementation of single-use technologies, the development of personalized and precision medicine, the growth of CDMO services, and an enhanced focus on sustainable bioprocessing methods. Key developments during this period encompass a greater embrace of single-use and modular bioprocessing setups, a rising requirement for adaptable small-scale bioprocessing in research and development, the broadening of contract biomanufacturing and outsourcing frameworks, an intensified concentration on scaling processes from laboratory to commercial stages, and the increasing integration of upstream and downstream bioprocess operations.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
Which Strong Drivers Are Impacting The Large And Small-Scale Bioprocessing Market Growth?
The increasing need for biologics is projected to drive the expansion of the large and small-scale bioprocessing market in the future. Biologics are defined as medical products originating from living organisms or their constituent parts, encompassing vaccines, blood and its constituents, gene therapies, tissues, and recombinant therapeutic proteins. This escalating demand for biologics stems from progress in biotechnology, enhanced comprehension of disease mechanisms, and the requirement for targeted and individualized treatments. Both large-scale and small-scale bioprocessing play crucial roles in the successful development and subsequent commercialization of biologics. Small-scale bioprocessing is vital for initial development phases, optimization efforts, and conducting feasibility assessments. Conversely, large-scale bioprocessing guarantees the efficient, consistent production of biologics, adhering to regulatory standards for their commercial distribution. As an illustration, in February 2024, data from the National Library of Medicine, a US-based medical library, indicated that in 2023, the Food and Drug Administration (FDA) authorized 55 new drugs, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), which represented a 50% increase over the 37 approvals recorded in 2022. Consequently, the rising demand for biologics is a key factor propelling the expansion of the large and small-scale bioprocessing market.
How Is The Large And Small-Scale Bioprocessing Market Categorized Across Its Segment Groups?
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors
2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents
3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes
5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags
6) Other Products: Mixers, Tubing And Connectors, Sampling Systems
Which Trends Are Contributing To Changes In The Large And Small-Scale Bioprocessing Market?
Companies within the large and small-scale bioprocessing market are prioritizing the creation of innovative solutions, such as fixed-bed, low-footprint bioreactor controllers, to address the growing need for high-productivity, cost-efficient, and scalable viral vector and advanced therapy manufacturing, a demand spurred by the rapid expansion of gene therapies, vaccines, and biologics. A fixed-bed, low-footprint bioreactor controller is a specialized hardware module designed to oversee large-area cell culture in fixed-bed reactors, providing a compact form factor, an intuitive user interface, and optimized fluid handling, unlike traditional large-scale stirred-tank bioreactors that require extensive physical space, significant capital investment, and complex infrastructure. For instance, in May 2025, Univercells Technologies SA, a Belgium-based bioprocessing company, introduced the scale-X Nitro Controller, engineered to operate their 200 m² and 600 m² scale-X Nitro fixed-bed bioreactors. This controller is presented as a compact, wheeled unit (1.6 m² footprint) capable of passing through standard cleanroom doors, supporting both adherent and suspension cultures, and featuring highly intuitive control. It facilitates rapid scale-up from R&D to commercial manufacturing (in ~8 months) while lowering cost-of-goods by 36–82% when compared to traditional adherent processes. Through the combination of high productivity with a simplified, space-saving design, the scale-X Nitro Controller assists biomanufacturers, particularly CDMOs and vaccine developers, in accelerating their development timelines and reducing financial obstacles for large-scale viral production.
Which Firms Are Influencing Competition In The Large And Small-Scale Bioprocessing Market?
Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, AbbVie Inc., Amgen Inc., Biogen Inc., Regeneron Pharmaceuticals Inc., Genentech Inc., Gilead Sciences Inc., Novo Nordisk A/S, CSL Limited, UCB S.A., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim
Get The Full Large And Small-Scale Bioprocessing Market Report:
Where Is The Large And Small-Scale Bioprocessing Market Primarily Concentrated By Region?
North America was the largest region in the large and small-scale bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Large And Small-Scale Bioprocessing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Large And Small-Scale Bioprocessing Market 2026, By The Business Research Company
Single Use Bioprocessing Market Report 2026
https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report
Bioprocessing Technology Market Report
https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report
Bioprocess Technology Market Report
https://www.thebusinessresearchcompany.com/report/bioprocess-technology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model